Discover

PSNL
Personalis, Inc.
13.79
2 x 10.07
2 x 17.15
bid
ask
+
0.39
2.91%
2 @ 07:03 AM
13.80 +0.01 (0.07%)
Ytd73.24%
1y83.62%
13.05
day range
14.18
3.84
52 week range
14.18
Open13.16Prev Close13.40Low13.05High14.18Mkt Cap1.44B
Vol3.94MAvg Vol2.77MEPS-1.02P/EN/AForward P/E-14.96
Beta2.28Short Ratio3.67Inst. Own68.19%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg8.69200-d Avg8.331yr Est10.86

PSNL News

benzinga.com
Personalis Wins EU Compliance Mark for Cancer Testing Blood Kits, Blood Collection Kits Receive Euro

Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announce

benzinga.com
Personalis Highlights Cancer-Detection Data Across Multiple Tumor Types

Personalis, Inc. (NASDAQ:PSNL) today announced clinical data from the 2026 American Society of Clini

benzinga.com
Personalis to Present New Cancer Detection Data at Major Oncology Conference

Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announce

US Agency Broadens Coverage Of Personalis Breast Cancer Test
benzinga.com
US Agency Broadens Coverage Of Personalis Breast Cancer Test

Personalis wins expanded Medicare coverage for NeXT Personal MRD test in breast cancer patients unde

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga.com
Morgan Stanley Maintains Equal-Weight on Personalis, Lowers Price Target to $9

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and lo

benzinga.com
BTIG Maintains Buy on Personalis, Lowers Price Target to $11

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and lowers the price targ

benzinga.com
Personalis Affirms FY2026 Sales Guidance of $78.000M-$80.000M vs $78.758M Est

Personalis (NASDAQ:PSNL) affirms FY2026 sales outlook from $78.000 million-$80.000 million to $78.00

benzinga.com
Personalis Q1 EPS $(0.29) Misses $(0.27) Estimate, Sales $15.472M Beat $14.483M Estimate

Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.29) per share which missed the analyst con

benzinga.com
Personalis Presents NeXT Personal ctDNA Data At AACR 2026 Showing 100% Sensitivity In Colorectal Can

Podium presentation on NeXT Personal monitoring neoadjuvant therapy in colorectal cancer;Real-world

benzinga.com
Personalis Showcases New Cancer Test To Track Treatment Resistance In Real Time

Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, announced toda

benzinga.com
Personalis Announces The Publication Of PREDICT-DNA Study In The Journal Of Clinical Oncology, Showi

The prospective study followed 227 patients with Triple-Negative (TNBC) and HER2+ breast cancer acro

benzinga.com
Morgan Stanley Maintains Equal-Weight on Personalis, Lowers Price Target to $10

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and lo

Breaking Down Personalis: 5 Analysts Share Their Views
benzinga.com
Breaking Down Personalis: 5 Analysts Share Their Views

benzinga.com
Needham Maintains Buy on Personalis, Raises Price Target to $12

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price ta

Earnings Breakdown: Personalis Q4
benzinga.com
Earnings Breakdown: Personalis Q4

benzinga.com
Personalis Q4 EPS $(0.26) Beats $(0.29) Estimate, Sales $17.345M Miss $17.383M Estimate

Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.26) per share which beat the analyst conse

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

benzinga.com
BTIG Maintains Buy on Personalis, Raises Price Target to $13

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price targ

Personalis Gets Medicare Coverage For Lung Cancer Surveillance Test
benzinga.com
Personalis Gets Medicare Coverage For Lung Cancer Surveillance Test

Personalis (PSNL) stock up in premarket on Medicare coverage for its NeXT Personal test for lung can

benzinga.com
Personalis Announced Medicare Coverage For Its NeXT Personal Molecular Residual Disease Test For Sur

This coverage determination is grounded in clinical evidence generated through the company's col

What 9 Analyst Ratings Have To Say About Personalis
benzinga.com
What 9 Analyst Ratings Have To Say About Personalis

benzinga.com
Guggenheim Maintains Buy on Personalis, Raises Price Target to $13

Guggenheim analyst Subbu Nambi maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price

Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday
benzinga.com
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Oth

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving L

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Earnings Scheduled For August 5, 2025

Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'
benzinga.com
Cramer Says Tesla Dominates While Ouster Is 'Too Speculative'

Jim Cramer advises against investing in Tempus AI due to its ongoing losses and suggests Pan Americ

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 27, 2025

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
benzinga.com
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbn

benzinga.com
Dow Surges Over 600 Points, Gold Jumps 1.5%

benzinga.com
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher

benzinga.com
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 112 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday's session, 406 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 169 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

benzinga.com
Earnings Scheduled For February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023